
Novonesis CEO Ester Baiget said that, while the Denmark biotech firm is resilient against U.S. tariffs, levies create uncertainty and pause investment.
.
Novonesis CEO Ester Baiget said that, while the Denmark biotech firm is resilient against U.S. tariffs, levies create uncertainty and pause investment.